N
DERM icon

Nuveen’s Journey Medical DERM Stock Holding History

Nuveen’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113K Buy
24,034
+8,324
+53% +$64.6K ﹤0.01% 3170
2025
Q4 		$121K Hold
15,710
– – ﹤0.01% 3200
2025
Q3 		$112K Hold
15,710
– – ﹤0.01% 3216
2025
Q2 		$113K Buy
+15,710
New +$109K ﹤0.01% 3241

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen's DERM Position: Q1 2026 in Review

Nuveen increased its Journey Medical (DERM) stake by 53% in Q1 2026, buying an estimated $64.6K and bringing the position to 24,034 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3170.

Nuveen first reported a position in DERM in Q2 2025 and has held it in 4 quarters since. The position peaked at $121K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Nuveen held 24,034 shares of Journey Medical worth $113K as of Q1 2026.
  • Nuveen bought 8,324 Journey Medical shares in Q1 2026, an estimated $64.6K.
  • Journey Medical made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3170 holding.
  • Nuveen first reported a position in Journey Medical in Q2 2025 and has held it in 4 quarters since.
  • Nuveen's Journey Medical position peaked at $121K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.